Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese

  • Michael A. Heneghan
  • Philip J. Johnson
  • Michael Clare
  • Stephen Ho
  • Phillip M. Harrison
  • Peter T. Donaldson
Research Article

Abstract

Background. The genetic basis of susceptibility to hepatocellular carcinoma (HCC) is poorly understood. Genomic DNA was available from 98 patients with HCC, 77 familial controls, 97 controls from Hong Kong and 96 Northern European controls (NECs).

Methods. Polymorphisms of interleukin (IL-1β; IL-1 receptor antagonist (IL-1RN); IL-10 promoter (positions −1082, −819, and −592); and tumor necrosis factor (TNF)-α promoter (TNF-α −238 and −308) were investigated.

Results. There was marked restriction in the distribution of the IL-1β and IL-1RN genotypes among Chinese subjects with a predominance of the IL-1β*1, 1 and IL-1RN*1, 1 (for unrelated controls compared with NECs only for IL-1β: x2=15.32, Pc=0.000091 and for IL-1RN: x2=16.08, Pc=0.000061). For IL-10, the distribution of alleles was reversed in Chinese vs NECs. The TNFA*2 allele (TNFA −308 A), which is associated with high TNF-α production both in vivo and in vitro, was found in <10% of Chinese but was present in 33% of NECs (x2=21.52, Pc<0.0000035).

Conclusion. Though this study failed to highlight specific associations between any of the polymorphisms tested and the HCC in Hong Kong Chinese, the differences in the distribution of tested alleles may, in part, account for the increased susceptibility of the Chinese population to develop HCC.

Key Words

Hepatocellular carcinoma immunogenetics gene polymorphism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bosch FX, Munoz N. Hepatocellular Carcinoma in the world: epidemiologic questions. In Tabor E, DiBisceglie AM, Purcell RH, eds. Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America. Houston: Gulf Publishing Co., 1991, pp. 35–54.Google Scholar
  2. 2.
    Johnson PJ. The epidemiology of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1996;8:845–849.PubMedGoogle Scholar
  3. 3.
    Hsu IC, Metcalf RA, Sun T, et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427–428.PubMedCrossRefGoogle Scholar
  4. 4.
    Aguilar F, Harris CC, Sun T, et al. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 1994;264:1317–1319.PubMedCrossRefGoogle Scholar
  5. 5.
    Lunn RM, Zhang YJ, Wang LY, et al. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 1997;57:3471–3477.PubMedGoogle Scholar
  6. 6.
    Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106:637–642.PubMedGoogle Scholar
  7. 7.
    Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095–2147.PubMedGoogle Scholar
  8. 8.
    Pociot F, Molvig J, Wogensen L, et al. A Taq1 polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396–402.PubMedCrossRefGoogle Scholar
  9. 9.
    Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in the human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403–404.PubMedCrossRefGoogle Scholar
  10. 10.
    Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1RA and IL-1B genes. Eur J Immunol 1998;28:2598–2602.PubMedCrossRefGoogle Scholar
  11. 11.
    Fanning G, Bunce M, Black CM, et al. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin α. Tissue Antigens 1997;50:23–31.PubMedCrossRefGoogle Scholar
  12. 12.
    Wilson AG, Di Giovine FS, Blakemore AIF, et al. Single base change in the human tumor necrosis factor (TNF-α) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992;1:353.PubMedCrossRefGoogle Scholar
  13. 13.
    Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195–3199.PubMedCrossRefGoogle Scholar
  14. 14.
    Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170–173.PubMedCrossRefGoogle Scholar
  15. 15.
    Kim JM, Brannan CL, Copeland NG, et al. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992;148:3618–3623.PubMedGoogle Scholar
  16. 16.
    Turner DM, Williams DM, Sankaran D, et al. Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 promoter. Eur J Immunogenet 1997;24:1–8.PubMedGoogle Scholar
  17. 17.
    Thompson K, Maltby J, Fallowfield J, et al. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 1998;28:1597–606.PubMedCrossRefGoogle Scholar
  18. 18.
    Louis H, Van Laethem JL, Wu W, et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998;28:1607–1615.PubMedCrossRefGoogle Scholar
  19. 19.
    Bioque G, Crusius JBA, Koutroubakis I, et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995;102:379–383.PubMedCrossRefGoogle Scholar
  20. 20.
    McGuire W, Hill AVS, Allsopp CEM, et al. Variation in the TNF-a promoter region associated with susceptibility of cerebral malaria. Nature 1994;371:508–511.PubMedCrossRefGoogle Scholar
  21. 21.
    D’Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenet 1994;39:150–154.Google Scholar
  22. 22.
    Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18–27.PubMedGoogle Scholar
  23. 23.
    Cookson S, Constantini PK, Clare M, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoinnune hepatitis. Hepatology 1999;30:851–856.PubMedCrossRefGoogle Scholar
  24. 24.
    Perrier S, Coussediere C, Dubost JJ, et al. IL-1 receptor antangonist (IL-1RA) gene polymorphism in Sjogren’s syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 1998;87:309–313.PubMedCrossRefGoogle Scholar
  25. 25.
    Wang Y, Kato N, Hoshida Y, et al. Interleukin-1 gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003;37:65–71.PubMedCrossRefGoogle Scholar
  26. 26.
    Moore KW, O’Garra A, De Waal Malefyt R, et al. Interleukin-10. Annu Rev Immunol 1993;11:165–190.PubMedCrossRefGoogle Scholar
  27. 27.
    Edwards-Smith CJ, Jonsson JR, Purdie DM, et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999;30:526–530.PubMedCrossRefGoogle Scholar
  28. 28.
    Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996;23:17–23.PubMedCrossRefGoogle Scholar
  29. 29.
    Guidotti LG, Borrow P, Hobbs MV, et al. Intracellular inactivation of the hepatitis B virus by cytotoxic B lymphocytes. Immunity 1996;4:25–36.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2003

Authors and Affiliations

  • Michael A. Heneghan
    • 1
    • 2
  • Philip J. Johnson
    • 3
  • Michael Clare
    • 1
  • Stephen Ho
    • 3
  • Phillip M. Harrison
    • 1
  • Peter T. Donaldson
    • 1
    • 4
  1. 1.Institute of Liver StudiesKing’s College HospitalLondonUK
  2. 2.Division of GastroenterologyDuke University Medical CenterDurhamUSA
  3. 3.Department of OncologyThe Chinese University of Hong KongHong Kong SARChina
  4. 4.Center for Liver Research, Faculty of Clinical Medical Sciences, The Medical SchoolUniversity of NewcastleNewcastle upon TyneUK

Personalised recommendations